Skip to main content
. 2018 Jul 25;7:F1000 Faculty Rev-1137. [Version 1] doi: 10.12688/f1000research.14903.1

Figure 1. Proposed substratification of intermediate-risk non-muscle-invasive bladder cancer (NMIBC) based on the recommendations of the International Bladder Cancer Group 35.

Figure 1.

BCG, bacillus Calmette-Guérin; TURBT, transurethral resection of bladder tumor.